What Happened To EZC Pak After Shark Tank?

EZC Pak is an immune support product developed by MD Sarath Malepati and The PPC Group, based in Los Angeles, California. The product was featured on Shark Tank Season 11, Episode 6, where Sarath Malepati sought $125,000 for 5% equity in the company, valuing it at $2.5 million.

EZC Pak is a natural alternative to antibiotics, designed to strengthen the immune system. Each pack contains a five-day supply of capsules, which combine Echinacea Purpurea, Zinc Acetate, and Vitamin C.

The retail price is $19.99 per pack or $99.99 for six packs. The product is available for purchase on Amazon and at selected CVS Pharmacy stores nationwide.

Company NameEZC Pak
FounderSarath Malepati
Founded2014
ProductVitamin and mineral-added herbal supplements.
Asked For$125k for 5% equity
Final Deal$125k for 5% + $1 royalty per unit until $450k is repaid
Shark Kevin O'Leary Shark Tank Profile Kevin O’Leary
Episode (Shark Tank USA)S11 E6
Air DateNov 3, 2019
Business StatusIn Business
WebsiteVisit Website
HeadquartersLos Angeles, California, United States
Lifetime Worth (Sales)$13.3M *estimated
Buy and WatchBuy NowAmazon Prime

Another Shark Tank Pitch

Who Is The Founder Of EZC Pak?

EZC Pak was founded in 2014 by Sarath Malepati, who is also a manager at The PPC Group. Sarath holds a Doctor of Medicine degree from Wake Forest University School of Medicine and has worked at NIHCM before joining The PPC Group in May 2013.

How Was The Shark Tank Pitch Of EZC Pak?

In Shark Tank Season 11 Episode 6, Sarath Malepati pitched EZC Pak, seeking $125,000 for 5% equity at a $2.5 million valuation. Sarath detailed the product’s benefits and explained the immune system through an animation.

He reported $1.2 million in sales for 2018, but with a net loss of $150,000 due to $750,000 in marketing expenses.

While all the Sharks initially declined, Kevin O’Leary showed interest. Kevin offered $125,000 for 5% equity plus a $0.60 royalty per unit in perpetuity.

Sarath countered with a $125,000 offer for 5% equity plus a $1 royalty per unit for 36 months.

Kevin then adjusted his offer to $125,000 for 5% equity plus a $1 royalty per unit until $500,000 was repaid. Sarath requested $400,000 but ultimately accepted Kevin’s final offer of $450,000.

Finalized: Kevin O’Leary invests $125k in exchange for 5% equity + a royalty of $1 per unit until $450k is repaid in “EZC Pak”.

What Happened To EZC Pak After Shark Tank?

In 2020, the demand for immune support products surged due to the COVID-19 pandemic, leading to a significant increase in the popularity of natural supplements.

During this period, EZC Pak experienced a remarkable 1000% increase in sales. The company also introduced a new product, “EZC Pak+D,” which includes Vitamin D for additional immune support.

As of June 2023, EZC Pak’s annual revenue has reached $4 million. The company’s products are available at major retailers such as CVS, Davidson Drugs, and various independent pharmacies.

The funding from Shark Tank, combined with the pandemic-driven demand, played a crucial role in boosting the company’s sales.

We’ll continue to monitor Sarath Malepati and EZC Pak for further updates.

What Is the Net Worth of EZC Pak?

EZC Pak’s current valuation is approximately $3.5 million. The global market for antibiotics is projected to reach USD 59.21 billion by 2030, highlighting significant growth potential in the sector.

Many individuals use antibiotics to enhance their immune system, underscoring the potential for products like EZC Pak in the market.

Annual Revenue by Years

Note: This report is based on our research and data so far. In this, we are only estimating the annual revenue.

YearsAnnual Revenue
2023$4M *estimated
2022$2.5M *estimated
2021$1.5M *estimated
2020$3.1M *estimated
2019$1M *estimated
2018$1.2M

Funding Reports to Date!

YearsFunding AmountInvestor
Nov 2019$125K (Seed Round)Kevin O’Leary

The company’s headquarters is located in Los Angeles, California, and it operates with a small team of 2-10 employees.

Yes, EZC Pak is still in business as of June 2023.

Leave a Reply

Your email address will not be published. Required fields are marked *